Company Overview of Sopherion Therapeutics, LLC
Sopherion Therapeutics, LLC operates as a biopharmaceutical company. The company, through its subsidiary, Sopherion Therapeutics Canada, develops and commercializes anti-cancer therapies for patients suffering with advanced cancer in North America. Its lead product candidate, Myocet, is in Phase III development stage for the first-line treatment of metastatic breast cancer. Sopherion Therapeutics, LLC was founded in 2001 and is based in Princeton, New Jersey with additional offices in Cheshire, Connecticut and Estero, Florida; and an operating subsidiary in Toronto, Canada.
104 Carnegie Center
Princeton, NJ 08540
Founded in 2001
Key Executives for Sopherion Therapeutics, LLC
Sopherion Therapeutics, LLC Key Developments
Similar Private Companies By Industry
|GITR Inc.||United States|
|EUSA Pharma, Inc.||United States|
|GeneriCo LLC||United States|
|Elixir Pharmaceuticals, Inc.||United States|
|InCode BioPharmaceutics, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Sopherion Therapeutics, LLC, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.